Abstract
2'-Deoxy-methanocarba nucleosides are a class of compounds with important antiviral and antitumor activities. (N)-2'-deoxymethanocarbathymidine, (N)-MCT, is known as active and specific agent against herpes simplex viruses (HSV1 and 2) and Kaposi's sarcoma- associated herpes virus (KSHV). Some analogues such MRS2500 and MRS2279 have potent antithrombotic therapeutic effect due to their interactions with the purinergic P2Y1 receptors as antagonists, which have led to the new drug concepts. In the present review for the first time is provided a whole overview of the reported several synthetic approaches to the different analogues of 2'-deoxymethanocarba nucleosides as well as their biological activity.
Keywords: (N)-MCT, total synthesis, conformationally restricted nucleosides, antiviral, antitumor activities
Current Organic Synthesis
Title:Synthetic Survey and Activity of 2'-deoxy-methanocarba Nucleosides
Volume: 10 Issue: 2
Author(s): Krassimira P. Guerra and Carlos A. M. Afonso
Affiliation:
Keywords: (N)-MCT, total synthesis, conformationally restricted nucleosides, antiviral, antitumor activities
Abstract: 2'-Deoxy-methanocarba nucleosides are a class of compounds with important antiviral and antitumor activities. (N)-2'-deoxymethanocarbathymidine, (N)-MCT, is known as active and specific agent against herpes simplex viruses (HSV1 and 2) and Kaposi's sarcoma- associated herpes virus (KSHV). Some analogues such MRS2500 and MRS2279 have potent antithrombotic therapeutic effect due to their interactions with the purinergic P2Y1 receptors as antagonists, which have led to the new drug concepts. In the present review for the first time is provided a whole overview of the reported several synthetic approaches to the different analogues of 2'-deoxymethanocarba nucleosides as well as their biological activity.
Export Options
About this article
Cite this article as:
P. Guerra Krassimira and A. M. Afonso Carlos, Synthetic Survey and Activity of 2'-deoxy-methanocarba Nucleosides, Current Organic Synthesis 2013; 10 (2) . https://dx.doi.org/10.2174/1570179411310020002
DOI https://dx.doi.org/10.2174/1570179411310020002 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Recent Imaging Advancements for Lung Metastases in Children with Sarcoma
Current Medical Imaging Eph Receptor Tyrosine Kinases in Tumor and Tumor Microenvironment
Current Pharmaceutical Design Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications
Current Pharmaceutical Design Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Injectable Thermosensitive Chitosan/Glycerophosphate-Based Hydrogels for Tissue Engineering and Drug Delivery Applications: A Review
Recent Patents on Drug Delivery & Formulation <sup>177</sup>Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Current Radiopharmaceuticals Status of Non-Classical Mononuclear Platinum Anticancer Drug Development
Mini-Reviews in Medicinal Chemistry Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments
Current Medicinal Chemistry Recent Progress in Phosphoinositide 3-Kinases: Oncogenic Properties and Prognostic and Therapeutic Implications
Current Protein & Peptide Science Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety
Recent Patents on Anti-Cancer Drug Discovery New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Current Medicinal Chemistry - Anti-Cancer Agents Specialisation of the Tropomyosin Composition of Actin Filaments Provides New Potential Targets for Chemotherapy
Current Cancer Drug Targets Biologically Active 4-Thiazolidinones: A Review of QSAR Studies and QSAR Modeling of Antitumor Activity
Current Topics in Medicinal Chemistry Secondary Radiation-Induced Bone Tumours Demonstrate a High Degree of Genomic Instability Predictive of a Poor Prognosis
Current Genomics ALK-Positive Non-Small Cell Lung Cancer; Potential Combination Drug Treatments
Current Cancer Drug Targets Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia
Current Cancer Drug Targets Targeted Inhibition of Angiogenic Factors in AIDS-related Disorders
Current Drug Targets - Infectious Disorders Targeting Lentiviral Vectors for Cancer Immunotherapy
Current Cancer Therapy Reviews